Microarray Analysis Market | Growth opportunities, Trends, Industry Analysis

Posted by vinit sawant on April 2nd, 2021

Overview:

A microarray is a multiplex lab-on-a-chip with a two-dimensional array present on a solid substrate that can be used to perform tests for people showing intense interest. The process helps researchers in investigating subjects and then address the concerns accordingly. It often involves subjects that are non-traceable. The process delivers quick results with great efficiency.

The microarray analysis market can grow in the coming years with 9.8% CAGR during the forecast period of 2018-2023. The global market is expected to ride on the profits provided by the pharmaceuticals sector, the healthcare industry, and various research institutes where better investments are getting included to impact the global market.

Segmentation:

The study regarding global microarray analysis market includes product type, type, application, and end-user. These segments are covering the market with an analysis of various data regarding volume and value.

By type, the market for microarray analysis includes tissue microarrays, chemical compound microarrays, protein microarrays, glycan arrays, DNA microarrays, phenotype microarrays, and cellular microarrays. The segment for DNA microarrays is holding the largest market share.

By application, the report for microarray analysis comprises disease diagnosis, drug discovery, proteomics, genotyping, research, forensic analysis, genomics, and toxicological research. The drug discovery segment may grow with the highest CAGR in the coming years.

By product type, the market study for microarray analysis can be segmented into primers, reagents, reagent kits, instruments, DNA chips, and buffers. The instrument segment can be sub-segmented into hybridization oven, Multi-Channel (MC) instrument, scanner, centrifuge, slide imprinters, target preparation instrument, and others.

By end-users, the market report on the microarray analysis has pharmaceuticals, academic & research institutes, hospitals & clinics, diagnostic centers, ambulatory care centers, biotechnology, and others.

Competitive Landscape:

Several companies are putting their best move forward to establish their names as great contributors to the market. In the process, they are increasing their investment and ensuring better focusing on several tracks. These companies are Discerna, NextGen Sciences PLC, Illumnia Inc., Thermo Fisher Scientific, ProteoGenix, Roche NimbleGen, Agilent Technologies Inc., Affymetrix Inc., Luminex Corporation, Biomerieux SA, Applied Microarrays, Gyros AB, Sequenom Inc., and others. MRFR made an effort in listing these companies and recording their recent contributions to ensure better market understanding of both trends and possible strategic shifts.